<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
San Francisco, California–(Newsfile Corp. – June 19, 2021) – Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to submit your losses now.Class Period: June 15, 2020 – Apr. 4, 2021Lead Plaintiff Deadline: June 21, 2021Visit: www.hbsslaw.com/investor-fraud/ACADContact An Attorney Now: ACAD@hbsslaw.com844-916-0895Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) Securities Fraud Action:The complaint alleges that Defendants misrepresented facts concerning Acadia’s supplemental new drug application
...read full article on Newsfile Corp
